U.S. drops another $2.1B for doses of experimental coronavirus vaccine candidate

Pharma giants GlaxoSmithKline and Sanofi Pasteur introduced Friday they’ll provide 100 million doses of an experimental COVID-19 vaccine to the US.

Leave a Reply

Your email address will not be published. Required fields are marked *